HMI-202

N/A

Report date: 2023/09/01 09:11:02

Base Information

Drug NameHMI-202
Drug Alias NameHMI-202
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionARSA gene transference
TargetsCerebroside-sulfatase
Therapy Area/IndicationsLeukodystrophy, Metachromatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQ32 Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesQ32 Bio Inc
Inactive CompaniesN/A
Active IndicationsLeukodystrophy, Metachromatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A